Carcinogenesis (HCV)
Long-Term, Low-Dose IFN May Prevent HCC
Published in Cancer Weekly, September 29th, 1997
Researchers in Great Britain suggest that it could.
Nikolai V. Naoumov and colleagues found that persistent hepatitis C virus (HCV) replication is closely associated with hepatocellular carcinoma development in cirrhosis, but that HCV genotypes are not associated with specific malignant transformations.
HCV is an RNA virus with no reverse transcriptase activity and no apparent mechanism for genomic integration. For this reason, it has been assumed that HCV is not directly oncogenic, but rather that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-09-29)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Combination Antisense/Chemotherapy Knocks Out Resistant Glioma Cells - Cancer Gene Therapy
First p53 Phase II Trial in Therapy Planned To Begin - Bladder Cancer (Diagnostics)
ImmunoCyt Commercialized for Cancer Diagnosis - Breast Cancer
At-Risk Women Want Breast Cancer Gene Test - If 'Pros' Outweigh 'Cons' - Breast Cancer
U.S. Government Research: Silicone Implants Don't Cause Cancer - Cancer Genetics (p53)
U.S. Research Finds How Key Anti-Cancer Gene Works - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
